Brainscreening

Company Overview

Snapshot

Founded in July 2017 by Pinhas Dannon, Brainscreening operates with 1–10 employees. The company is currently in a Pre-Funding stage and ceased operations in January 2022.

Business overview

Brainscreening develops a web-based tool for home-based assessment of cognitive functions. Its core product provides a legitimate alternative to clinic-based tests, enabling patients to perform assessments on a home computer. The platform serves individuals and referring physicians, offering insights into cognitive functioning for various medical disorders such as ADHD, memory disorders, addictions, and head trauma, and can predict treatment responses for certain conditions. Brainscreening operates within the Digital Medical Diagnostics sector of Health Tech & Life Sciences.

Company Intelligence Q&A

What is Brainscreening's primary offering?

Brainscreening provides a web-based tool designed for home-based assessment of cognitive functions, offering a convenient alternative to traditional clinical evaluations.

Which medical conditions does Brainscreening's assessment cover?

The assessment includes several validated medical disorders such as ADHD, memory disorders, addictions, and head trauma, and can predict responses to treatment for certain conditions.

Who are the target users of Brainscreening's platform?

Brainscreening directs test results and reports to either the examinee directly or to a referring physician, serving both patients and healthcare professionals.

When was Brainscreening founded?

Brainscreening was founded in July 2017.

What is the current operational status of Brainscreening?

Brainscreening is currently non-active, having ceased operations in January 2022.